Yu Zhang
Kunming University of Science and Technology(CN)Beijing Union University(CN)Ministry of Education Science and Technology(MW)Guizhou Normal University(CN)Guizhou University(CN)Shanghai University of Traditional Chinese Medicine(CN)National Institute of Allergy and Infectious Diseases(US)Office of Extramural Research(US)VIB-KU Leuven Center for Brain & Disease Research(BE)
Publications by Year
Research Areas
Immunodeficiency and Autoimmune Disorders, Immune Cell Function and Interaction, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, T-cell and B-cell Immunology
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → Inborn errors of type I IFN immunity in patients with life-threatening COVID-19(2020)2,377 cited
- → Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4(2014)829 cited
- → Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy(2015)670 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations(2014)547 cited